Dr. Caleb Lee, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10100 Fairfax Blvd, Fairfax, VA 22030 Phone: 703-679-1876 |
Dr. Monica Nabil Saleh Valentin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11351 Random Hills Rd, Fairfax, VA 22030 Phone: 443-351-3376 |
Dr. Kathleen Ellison, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd Ste 400, Fairfax, VA 22031 Phone: 703-641-0083 Fax: 703-641-0085 |
Jack Michael Costa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3650 Joseph Siewick Dr, Suite 202, Fairfax, VA 22033 Phone: 703-391-2516 Fax: 703-476-8244 |
Dr. Amanda Derwae, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 10680 Main St Ste 200, Fairfax, VA 22030 Phone: 703-352-2620 |
Dr. Rolla Jaber, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3700 Joseph Siewick Dr, Suite 403, Fairfax, VA 22033 Phone: 703-648-2488 Fax: 703-648-2489 |
Amanda Unalivia Buracker, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8505 Arlington Blvd Ste 210, Fairfax, VA 22031 Phone: 703-846-0076 Fax: 703-846-0025 |
Dr. Jeffrey F Scott, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3700 Joseph Siewick Dr Ste 402, Fairfax, VA 22033 Phone: 703-620-8900 Fax: 703-620-2288 |
Dr. Alan Ellis Rolfe, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 8505 Arlington Blvd Ste 210, Fairfax, VA 22031 Phone: 703-846-0076 Fax: 703-846-0025 |
Dr. Suraj S Venna, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 |
Blair Saunders Allais, MD Dermatology Medicare: Medicare Enrolled Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-7040 Fax: 571-472-0241 |
Alexandra Kazakis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3022 Williams Dr, Suite 101, Fairfax, VA 22031 Phone: 703-573-5252 Fax: 703-573-5254 |
Dr. Michele Zerah Magnino, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3025 Hamaker Ct Ste 300, Fairfax, VA 22031 Phone: 703-849-8036 Fax: 703-204-3448 |
Mr. Charles Martin Aaronson, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3606 Lido Pl., Fairfax, VA 22031 Phone: 703-273-5263 |
Kristin Lee Khan, MD Dermatology Medicare: Medicare Enrolled Practice Location: 11351 Random Hills Rd, Fairfax, VA 22030 Phone: 443-351-3376 |
Fiona Shaw, Dermatology Medicare: Medicare Enrolled Practice Location: 8316 Arlington Blvd Ste 400, Fairfax, VA 22031 Phone: 703-832-9176 |
Dr. James Austin Cox, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3930 Pender Dr Ste 210, Fairfax, VA 22030 Phone: 703-828-7128 Fax: 703-825-7718 |
Harry Wilmer Wyre Jr., M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3700 Joseph Siewick Dr, Suite 404, Fairfax, VA 22033 Phone: 703-620-8900 Fax: 703-620-2288 |
Saundra L Seaman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8505 Arlington Blvd, Suite 210, Fairfax, VA 22031 Phone: 703-846-0076 Fax: 703-846-0025 |
Dr. Liana Abramova, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3930 Pender Dr Ste 210, Fairfax, VA 22030 Phone: 703-828-7128 Fax: 703-825-7718 |
News Archive
In the human brain, cells talk to one another through the routine exchange of electrical signals. But when people fall into a deep sleep, the higher regions of the brain - regions that during waking hours are a bustling grid of neural dialogue - apparently lose their ability to communicate effectively, causing consciousness to fade.
The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections.
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
Since the start of the novel coronavirus outbreak in late December 2019, doctors and health officials have imposed a quarantine period of 14 days since the estimated incubation period of the virus was expected to be between three and 14 days. A new study affirms that it may take about five days after exposure before patients manifest the symptoms of the disease.
› Verified 6 days ago